Lazard Asset Management »

Proqr Thrapeutics N V shs euro shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $0 5.9k 0.00
2023-09-30 $0 6.2k 0.00
2023-06-30 $0 5.9k 0.00
2023-03-31 $0 5.8k 0.00

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Alphabet Inc A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Norfolk Souther Common Stock (NSC)
Visa Common Stock (V)
Accenture Common Stock (ACN)
Intercontinen Common Stock (ICE)
Unitedhealth Gr Common Stock (UNH)
Aon Plc/ireland Common Stock (AON)
Bank Of America Common Stock (BAC)
Thermo Fisher Common Stock (TMO)
Analog Devices Common Stock (ADI)
Mcdonalds Corp Common Stock (MCD)
John & John Common Stock (JNJ)
Amer Express Common Stock (AXP)

View all positions for Lazard Asset Management

Top funds holding Proqr Thrapeutics N V shs euro

Privium Fund Management B.V.
EcoR1 Capital
M28 Capital Management
DAFNA Capital Management
Ikarian Capital
Millennium Management
Deutsche Bank Aktiengesellschaft
Monaco Asset Management SAM
Two Sigma Advisers
Franklin Street Advisors
Squarepoint Ops
Citadel Advisors
Two Sigma Investments
Bank of America Corporation
Virtu Financial

View all funds holding Proqr Thrapeutics N V shs euro